logo

For the Inventor, By the Inventor

Waltham, MA, United States of America

Kala Pharmaceuticals, Inc.


USPTO Granted Patents = 53

% Expired Patents = 43.4



Trademarks = 1

Forward Citations = 217

Loading Chart...
Loading Chart...

21 inventors (with patents filed for the assignee):

goldMedal Winston Zapanta Ong (46 out of 47 patents)

silverMedal Pawel Wojciech Nowak (30 out of 31 patents)

bronzeMedal Jinsoo Kim (23 out of 23 patents)

4.  Elizabeth M Enlow (19 out of 38 patents)

5.  Minh Ngoc Nguyen (18 out of 18 patents)

6.  Ben C Askew (15 out of 52 patents)

7.  Alexey Popov (9 out of 30 patents)

8.  John Thomas Feutrill (8 out of 8 patents)

9.  Hongming Chen (7 out of 26 patents)

10.  James Bourassa (7 out of 26 patents)

11.  Justin Scot Hanes (5 out of 71 patents)

12.  Colin R Gardner (4 out of 13 patents)

13.  Laura M Ensign (4 out of 20 patents)

14.  Tao Yu (4 out of 13 patents)

15.  Ming Yang (4 out of 16 patents)


Core Competencies:
Therapeutic Compounds
Urea Derivatives
Nanocrystals
Poly(vinyl Alcohol)
Particle Transport
VEGFR2 Inhibitors
Crystalline Forms
Meropenem Derivatives
Biochemical Binding
Functionalized Copolymers
Polymer Compositions
Drug Delivery

53 patents:

1. 11713323 - Crystalline forms of therapeutic compounds and uses thereof (2023-08-01),
2. 11401260 - Biochemical binding of RET9 and VEGFR2 inhibitors (2022-08-02),
3. 11369611 - Therapeutic compounds and uses thereof (2022-06-28),
4. 11352343 - Urea derivatives and uses thereof (2022-06-07),
5. 11318088 - Compositions and methods utilizing poly(vinyl alcohol) and/or other polymers that aid particle transport in mucus (2022-05-03),
6. 11104685 - Crystalline forms of therapeutic compounds and uses thereof (2021-08-31),
7. 11091487 - Meropenem derivatives and uses thereof (2021-08-17),
8. 11021487 - Crystalline forms of therapeutic compounds and uses thereof (2021-06-01),
9. 10975090 - Crystalline forms of therapeutic compounds and uses thereof (2021-04-13),
10. 10966987 - Therapeutic compounds and uses thereof (2021-04-06),
11. 10954244 - Compounds and uses thereof (2021-03-23),
12. 10875857 - 1-amino-triazolo(1,5-A)pyridine-substituted urea derivative and uses thereof (2020-12-29),
13. 10766907 - Crystalline forms of therapeutic compounds and uses thereof (2020-09-08),
14. 10758539 - Therapeutic compounds and uses thereof (2020-09-01),
15. 10723719 - Urea derivatives and uses thereof (2020-07-28),
Kala Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for eye diseases. Leveraging its proprietary mucus-penetrating particle (MPP) technology, Kala is targeting diseases of the front and back of the eye. The company's product portfolio includes treatments for dry eye disease, post-surgical inflammation, and inflammation and pain following cataract surgery.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Kala Pharmaceuticals, Inc.
53 Patents

#32 in Waltham, MA

#377 in Massachusetts

#6,661 in US

#13,309 in the World

Waltham, MA (US)
Waltham, MA, United States of America

Kala Pharmaceuticals, Inc.

Forward Citations = 217

21 inventors:

goldMedal Winston Zapanta Ong (46 out of 47 patents)

silverMedal Pawel Wojciech Nowak (30 out of 31 patents)

bronzeMedal Jinsoo Kim (23 out of 23 patents)

4.  Elizabeth M Enlow (19 out of 38 patents)

5.  Minh Ngoc Nguyen (18 out of 18 patents)

Please report any incorrect information to [email protected]
Loading…